Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Mar 12;151(4):532–554. doi: 10.1085/jgp.201812294

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Zawieja et al.

This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).

PMC Copyright notice

Figure 10. — Effect of the Ano1 inhibitor benzbromarone on sharp electrode LMC membrane potential of pressurized IALV. Representative 20-s membrane potential recording made with sharp electrode impalement of a LMC from a pressurized IALV under control perfusion with Krebs solution (A) and in response to 5 µM benzbromarone (B). The recorded action potentials were analyzed to assess: action potential frequency (C), resting membrane potential (D), the linear diastolic depolarization rate (E), action potential initiation threshold potential (F), the steepness of the action potential upstroke (G), peak voltage achieved during the action potential (H), the plateau voltage (I), and plateau duration (J). *, P < 0.05 comparing 5 µM benzbromarone versus Krebs at n = 6.